Delivery Order SPE2DB20D3101-SPE2DB22FK5A7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Chloroquine Phosphate 500 mg tablets in quantities of 25 units, with a ceiling value of $7,177.98. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The work is to be completed by November 21, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a $23,360.92 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide chloroquine phosphate. The contract has a completion date of July 21, 2023. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,033.97 by the Defense Logistics Agency on November 7, 2025, for the supply of Plaquemine 200 mg tablets (100-count). This competitive, non-set-aside delivery order carries a firm fixed price structure and is scheduled for ultimate completion by November 10, 2025. The contract represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025. This firm fixed-price contract, which is not set-aside and competitively awarded, is scheduled for completion by September 2, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,731.52 Firm Fixed Price Delivery Order contract is for the supply of 4565272230 - HYDROCODONE-ACETAMN 7.5-325/15 473ML, with a period of performance through July 29, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant $999,999,999...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $46,528.57 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed price and runs through November 2024, is for the supply of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. AmerisourceBergen also holds a larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $138,410.43 and a completion date of June 27, 2025, does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and will be providing a range of pharmaceutical products and medical supplies, including...
- This federal contract award, valued at $1,044,514.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling Amerisourcebergen to supply a wide range of...
- This is a firm fixed-price delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is valued at $946,668.04 and has a period of performance through June 13, 2025. Under this contract, Amerisourcebergen will provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $736,053.04 and a performance period through May 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK5A7Delivery Order
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,932,255 tablets of Hydroxychloroquine 200 mg, a critical pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $8,276.28 and a completion date of July 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating it was open to competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/28/22 |